In conclusion, our findings shed light on a new subgroup of B-ALL, including BCR-ABL1 positive and B-NEG patients, characterized by a unique signature dependent on Ikaros deletion. The gene discussed is IKZF1; the disease is acute lymphoblastic leukemia.